GLP-1 receptor agonist peptides for metabolic research — Semaglutide, Tirzepatide and Retatrutide. HPLC verified ≥99% purity, full Certificate of Analysis with every vial, express cold-chain shipping worldwide.
Buy GLP-1 receptor agonist peptides online — Semaglutide, Tirzepatide, and Retatrutide — all HPLC-verified at ≥99% purity with full Certificate of Analysis. This category covers the most significant class of metabolic peptides discovered in the last two decades. GLP-1 agonists mimic the incretin hormone glucagon-like peptide-1, activating receptors that control glucose-dependent insulin secretion, glucagon suppression, gastric emptying and hypothalamic appetite regulation. Semaglutide is the gold-standard mono-agonist with a seven-day half-life enabling once-weekly research protocols. Tirzepatide is a dual GIP/GLP-1 agonist delivering more pronounced metabolic effects in preclinical obesity and insulin-resistance models. Retatrutide adds a third pathway — glucagon receptor agonism — making it the newest tri-agonist research compound. All products are synthesized under cGMP conditions, shipped in temperature-controlled packaging, and suitable for research into obesity, type-2 diabetes, metabolic syndrome, and NAFLD models. Complete dosing, reconstitution and storage guidance ships with every order. Complementary research tools are available in our growth-hormone and tissue-repair categories — most metabolic protocols pair a GLP-1 agonist with either a GH secretagogue stack or a recovery peptide like BPC-157.
GLP-1 receptor agonists mimic the incretin hormone GLP-1, which is naturally released after eating. They slow gastric emptying, enhance insulin secretion, suppress glucagon, and act on hypothalamic appetite centers — providing multiple mechanisms for metabolic research.
Semaglutide is the most potent GLP-1 agonist currently available for research. Its modified amino acid sequence and fatty acid side chain give it an extended half-life of approximately 7 days, enabling once-weekly dosing protocols in research settings.
Tirzepatide represents the next generation: a dual GIP/GLP-1 receptor agonist. By targeting both incretin pathways simultaneously, it produces more pronounced metabolic effects than GLP-1 mono-agonists in preclinical models.
GLP-1 agonists are essential tools for studying glucose-dependent insulin secretion, beta-cell preservation, central appetite regulation, and cardiovascular protection mechanisms in metabolic disease models.
Semaglutide is a pure GLP-1 receptor agonist, while Tirzepatide is a dual GIP/GLP-1 receptor agonist. Tirzepatide targets two incretin pathways simultaneously, which research suggests may produce stronger metabolic effects.
GLP-1 agonists are supplied as lyophilized powder. Reconstitute with bacteriostatic water by slowly dispensing along the vial wall. Never shake — gently swirl until dissolved. Store reconstituted solution at 2-8°C.
All GLP-1 agonists are independently HPLC verified at ≥99% purity with mass spectrometry confirmation. Full Certificate of Analysis included with every order.
A Physician's Endorsement
Quality assurance isn't a marketing claim — it's a daily decision. I choose LifeSpanSupply because every batch is independently HPLC-verified to 99% purity, fully traceable, and held to the safety standards my patients deserve.
Dr. Pichaya Sangaunmu
M.D. · Wellness · Beauty · Longevity
3 products
Weight LossBestsellerSupreme Biologics
Triple GIP/GLP-1/glucagon receptor agonist — next-generation incretin under active clinical investigation.
Weight LossCalyssee
Triple GIP/GLP-1/glucagon receptor agonist — next-generation incretin under active clinical investigation.
Weight LossWolf
Triple GIP/GLP-1/glucagon receptor agonist — next-generation incretin under active clinical investigation.